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Structure of the CLC-1 chloride channel
from Homo sapiens
Eunyong Park, Roderick MacKinnon*
Laboratory of Molecular Neurobiology and Biophysics, Howard Hughes Medical
Institute, The Rockefeller University, New York, United States
Abstract CLC channels mediate passive Cl  conduction, while CLC transporters mediate active
Cl  transport coupled to H+ transport in the opposite direction. The distinction between CLC-0/1/2
channels and CLC transporters seems undetectable by amino acid sequence. To understand why
they are different functionally we determined the structure of the human CLC-1 channel. Its
‘glutamate gate’ residue, known to mediate proton transfer in CLC transporters, adopts a location
in the structure that appears to preclude it from its transport function. Furthermore, smaller side
chains produce a wider pore near the intracellular surface, potentially reducing a kinetic barrier for
Cl  conduction. When the corresponding residues are mutated in a transporter, it is converted to a
channel. Finally, Cl  at key sites in the pore appear to interact with reduced affinity compared to
transporters. Thus, subtle differences in glutamate gate conformation, internal pore diameter and
Cl  affinity distinguish CLC channels and transporters.
DOI: https://doi.org/10.7554/eLife.36629.001
Introduction
Transporters – also known as pumps – and channels both mediate the transfer of ions and molecules
across biological membranes. But the two are thermodynamically contrasting: transporters require
the input of external energy while channels are passive, meaning the substrate simply diffuses down
its electrochemical gradient. Except in rare cases, transporters and channels correspond to separate,
unrelated structural families. CLC proteins are one of the exceptions. Channel-forming CLCs are pas-
sive Cl  conductors (Jentsch et al., 1990; Miller and White, 1984), while transporter-forming CLCs
exchange, with fixed stoichiometry, two Cl  ions and one proton (H+) in opposite directions (i.e.,
they are Cl /H+ antiporters) (Accardi and Miller, 2004; Picollo and Pusch, 2005; Scheel et al.,
2005). The external energy input in CLC transporters comes from the energetic coupling of the
transported ions, Cl  and H+, such that the electrochemical gradient of one ion drives movement of
the other. The puzzling aspect of this dual functionality within the CLC protein family is that at the
level of amino acid sequence, the distinction between the channels and transporters is not apparent.
Conceptually, the distinction between channels and transporters in general has been explained in
terms of gating models that invoke one or two primary gates: channels are described as pores with
one gate and transporters as pores with two gates that are never permitted to open simultaneously
(Figure 1) (for review see [Gadsby, 2009]). While it is true that channels and transporters are most
often unrelated structurally, the gating model description implies that, in principle, similar structures
could give rise to both, as one can imagine that a transporter could become a channel if one or both
gates are compromised. CLC channels seem to fall under this category of channels that emerged
from a family of transporters (Accardi and Picollo, 2010; Lı´sal and Maduke, 2008; Miller, 2006).
Structural and functional studies support a plausible mechanistic model for the operation of CLC
transporters. CLC transporter structures show a narrow Cl  transport pathway with three consecu-
tive Cl -binding sites, referred to as Sext, Scen and Sint, for external (nearest the extracellular solu-
tion), central and internal (nearest the intracellular solution), respectively. Chloride is observed at
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these sites in various structures (Dutzler et al., 2002; Dutzler et al., 2003; Feng et al., 2010;
Jayaram et al., 2011). In addition, the transporters all contain a glutamate residue positioned such
that its side chain carboxylate group can bind either at Sext or Scen – in competition with a Cl
  ion –
or reside in the extracellular solution. Thus, CLC transporters are like Cl  channels with a weird fea-
ture – a glutamate side chain that clogs its own pore. This led to the idea that glutamate might not
only be a competitor for the Cl  binding sites as the structures suggest, but it might also transfer a
proton from inside to out (or the reverse) when it moves between its Scen position to its extracellular
position (Feng et al., 2010; Feng et al., 2012). The transfer would naturally give rise to the 2:1 Cl :
H+ exchange stoichiometry characteristic of CLC transporters because 2 Cl  ions must be displaced
when the glutamate gate moves between the extracellular solution and Scen. This mechanism is con-
sistent with the demonstrated conversion of a CLC transporter into a passive (but slow) Cl  channel
upon mutation of the glutamate, as well as the demonstrated ability of small carboxylate-containing
organic acids to compete with Cl  inside the pore (Accardi et al., 2004; Accardi and Miller, 2004;
Feng et al., 2012). But there was one important caveat to make this transporter mechanism work:
there must exist a relatively high kinetic barrier to Cl  flow near the intracellular side of the pore
(Feng et al., 2010). This barrier would serve as the ‘second gate’ in the gating model conceptualiza-
tion of transporters. So far, data for CLC transporters seem consistent with this mechanism: they
have a channel-like pore, an external ‘glutamate gate’ that competes with Cl  binding and (presum-
ably) transfers H+ across the membrane, and structurally what appears to be a relatively high resis-
tance (i.e., a large kinetic barrier) to Cl  flow near the intracellular aspect of the pore (i.e., the pore
there is very narrow.)
eLife digest Channels and transporters are two classes of proteins that transport molecules and
ions – collectively referred to as “substrates” – across cell membranes. Channels form a pore in the
membrane and the substrates diffuse through passively. Transporters, on the other hand, actively
pump substrates across a membrane, consuming energy in the process. Thus, channels and
transporters work in distinct ways.
Channels and transporters most often have unrelated structures, but there are rare examples of
both existing within the same family of structurally similar proteins. CLC proteins, for example,
include both chloride ion channels and transporters that pump chloride ions in one direction by
harnessing the energy from hydrogen ions flowing in the other direction.
It remains unclear why some CLC proteins work as channels while others are transporters,
especially since the two seem indistinguishable on the basis of the order of their amino acids – the
building blocks of all proteins. The conservation of the amino acid sequences implies they are
structurally very similar. How then can different members perform such energetically distinct
processes?
Park and MacKinnon now show that the answer to this question serves as a reminder of how
subtle nature can be. Indeed, while the structure of a human CLC channel (called CLC-1) is indeed
similar to those of CLC transporters, one amino acid adopts a unique shape that explains why the
protein cannot act as a transporter. This specific amino acid, a glutamate, is central to the exchange
of chloride and hydrogen ions in CLC transporters. Park and MacKinnon show that its conformation
in the CLC-1 channel stops this exchange, while leaving the pore open for the passive transport of
chloride ions. Also, two other amino acids along the ion diffusion pathway in the CLC channel are
smaller than their counterparts in CLC transporters, and so allow chloride ions to diffuse through
more quickly. Lastly, Park and MacKinnon also note that channels do not require a wide pore:
instead ions can still flow rapidly through a narrow pore if the chemical environment inside permits
it.
CLC proteins perform a number of important roles in humans, and mutations in CLC-encoding
genes underlie numerous heritable diseases. It remains too early to know how this mechanistic study
may or may not impact treatments, yet the findings will likely interest scientists working on ion
conduction mechanisms and the evolution of molecular function.
DOI: https://doi.org/10.7554/eLife.36629.002
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Less is known about the chemistry and structure of CLC channels. Only one CLC channel structure
has been determined, CLC-K from Bos taurus (referred to as bCLC-K or shortly CLC-K) (Park et al.,
2017). This is a special case, a rare type of CLC channel that can be distinguished from CLC trans-
porters based on its amino acid sequence because it does not have a ‘glutamate gate’. That differ-
ence alone renders CLC-K inert to H+ transfer. The structure of CLC-K also revealed a wider pore
diameter on the intracellular side, consistent with a lowered kinetic barrier to Cl  flow. CLC-0/1/2
channels, by contrast, contain a ‘glutamate gate’ and are not distinguishable from CLC transporters
by sequence. Thus, there must be an even more subtle distinction between these CLC channels and
the transporters. Why does the glutamate gate in these channel CLCs not give rise to H+ transfer
coupled to Cl  transfer? Is a reduced kinetic barrier to Cl  flow near the intracellular side, suggested
by the CLC-K structure, a common feature in CLC channels? To address these questions, we have
determined the structure of CLC-1 from Homo sapiens (referred to as hCLC-1 or CLC-1).
We are also interested in the CLC-1 channel because it plays an important role in membrane
repolarization of skeletal muscle cells following muscular contraction, and its mutation in humans
causes hereditary muscle disorders known as myotonia congenita (George et al., 1993; Koch et al.,
1992; Lorenz et al., 1994; Steinmeyer et al., 1991).
Results
Determination of a human CLC-1 channel structure by cryo-EM
We purified the CLC-1 protein in mild detergent from cultured human cells and examined them by
cryo-EM single particle analysis (Figure 2 and Figure 2—figure supplements 1 and 2). Despite its
small molecular size (200 kDa), particles showed good contrast on micrographs under the optimized
freezing and data acquisition conditions (Figure 2A). Two-dimensional (2D) class averages of
selected particles displayed 2-fold rotational symmetry around an axis normal to the membrane
(detergent micelle) (Figure 2B), as expected from the homodimeric architecture of CLC proteins
(Dutzler et al., 2002; Ludewig et al., 1996; Miller and White, 1984). After removing artifacts and
damaged particles by 2D classification, a density map was reconstructed at 3.9 A˚ resolution with C2
symmetry imposed (Figure 2—figure supplement 1B). This map showed a well-resolved transmem-
brane domain (TMD) with clearly visible a-helical features. By contrast, density for the carboxy-termi-
nal cytosolic domain (CTD) was lower quality, suggesting conformational flexibility in this region.
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Figure 1. Passive and active transport explained by gating mechanisms. One-gate (A) and two-gate (B) models explaining passive transport by a
channel and active transport by a transporter (shown is an antiporter). Direction of the solute electrochemical gradient is indicated by a wedge (the
thicker end means more positive).
DOI: https://doi.org/10.7554/eLife.36629.003
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Figure 2. Cryo-EM structure of the human CLC-1 channel. (A) Representative micrograph of the purified CLC-1
channel (scale bar, 50 nm) on a cryo-EM grid. Representative particles (white squares) are magnified and shown in
the right panels. (B) Images of selected 2D classes from reference-free 2D classification by RELION. Scale bar, 10
nm. (C and D) Cryo-EM density map (C) and atomic model (D) of the hCLC-1 channel. The transmembrane domain
(TMD; blue and salmon) and the cytosolic domain (CTD; light blue and tan) were separately refined and combined
for visualization. Ext, extracellular side. Int, intracellular side. The approximate lipid bilayer region is shown by
arrows.
DOI: https://doi.org/10.7554/eLife.36629.004
The following figure supplements are available for figure 2:
Figure supplement 1. Sample preparation and cryo-EM image processing procedures.
DOI: https://doi.org/10.7554/eLife.36629.005
Figure supplement 2. Quality of the cryo-EM map and atomic model of CLC-1.
DOI: https://doi.org/10.7554/eLife.36629.006
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To improve the map quality, we subjected particles to a round of 3D classification (Figure 2—fig-
ure supplement 1B). The results demonstrated that while the TMD is largely indistinguishable
between classes, the CTDs deviate from each other by pivotal movements of varying degrees (Fig-
ure 2—figure supplement 1C). Based on this, we pooled ~170,000 particles from the two most
populated and structurally similar classes, which correspond to 50% of particles. This particle set led
to an improved density map at an overall resolution of 3.6 A˚ (data not shown). Using masking techni-
ques to isolate individual regions, the resolution of the TMD was further improved to 3.4 A˚
(Figure 2C, Figure 2—figure supplement 1B, Video 1). The CTD remained poorly defined, likely
due to continuous pivotal movements of its two wing-like structures (Figure 2C, Figure 2—figure
supplement 1C, Video 1).
The good quality TMD density map enabled building a molecular model that included nearly all
side chains (Figure 2C, Figure 2—figure supplement 2, and Video 1). The model was refined using
Rosetta (Wang et al., 2016). The CTD map did not show side chain density but we could dock with
confidence the crystal structure of the CLC-0 CTD (Figure 2D and Figure 2—figure supplement
1D) (Meyer and Dutzler, 2006). Both CLC-1 and CLC-0 channels contain a large loop extending
from the CTD’s cystathionin-b-synthase (CBS) domains, which was not visible in either the EM density
map or the crystal structure. The function of the CTD is poorly understood; it may even be dispens-
able for ion transport given its high tolerance to mutation (Este´vez et al., 2004) and absence in
most bacterial CLC transporters.
Bifurcated pore structure of CLC-1
The TMD of CLC-1 exhibits the canonical dimeric architecture of a CLC protein (Figure 2C,D). Each
monomer is roughly a triangular prism shape and contains a complete ion transport pathway that
appears structurally independent from that of the neighboring monomer. As in other CLC structures
(Dutzler et al., 2002; Dutzler et al., 2003; Feng et al., 2010; Park et al., 2017), the Cl  transport
pore in CLC-1 is most narrowly constricted halfway across the membrane, within the region referred
to as the selectivity filter (Figure 3A). Overall, the pore lining is charged positive to attract Cl 
(Figure 3B).
In contrast to other CLC proteins the potential route for ion diffusion in CLC-1 is bifurcated on
the intracellular side of the selectivity filter– one following the canonical Cl  transport pathway found
in all CLC proteins and the ‘second’ pore directed toward the protomer-protomer boundary on the
cytosolic surface, which is distinctive in CLC-1 (Figure 3A,B and Figure 3—figure supplement 1).
Both branches of the bifurcation are potentially hydrated because the radius is greater than that of
water (1.4 A˚) and the linings contain chemical groups with hydrogen bonding potential. A branch
equivalent to CLC-1’s secondary pore in the CLC-K channel is sealed off by F222 and V226 (corre-
sponding to F288 and V292 of CLC-1) due to a different aH helix position (Figure 3C). In transport-
ers, only a much narrower (~0.9–1.0 A˚ radius) pore could be detected, where stable dwelling of
water molecules seems unlikely (Figure 3—figure supplement 1). In the E. coli transporter (EcCLC),
the pore is further capped near the cytosolic surface by E203 (corresponding to V292 of CLC-1). We
note that E203 of EcCLC and the equivalent Glu
of mammalian CLC-4 and CLC-5 transporters
have been implicated in shuttling H+ between
the intracellular solvent and the protein interior
(Lim and Miller, 2009; Lim et al., 2012;
Zdebik et al., 2008) by side-chain protonation
and deprotonation, although this feature does
not seem to be essential for H+ transport in
other cases, including the C. merolae transporter
(CmCLC) (Feng et al., 2010; Feng et al., 2012;
Phillips et al., 2012). It is possible that during
Cl /H+ exchange cycles, the aH helix of trans-
porters transiently undergoes a conformational
change such that a water-accessible pore is
formed similarly to the CLC-1 case, which might
facilitate H+ transfer. Unlike transporter-type
CLCs, the CLC-1 channel does not transport H+
Video 1. Cryo-EM structure of the human CLC-1
channel. The cryo-EM map and atomic model of
human CLC-1 are illustrated. Also see Figure 2C and
D.
DOI: https://doi.org/10.7554/eLife.36629.007
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in a manner tightly coupled to Cl  and thus it is unclear whether CLC-1’s second intracellular pore is
utilized for ion transport. Cl  ions may move through this pore in addition to the primary Cl 
pathway.
Chloride-selectivity filter and bound Cl  ions
The CLC-1 structure shows an anion selectivity filter largely similar to other CLC proteins but with
some distinctive features (Figure 4A and Video 2). The filter is formed at the central constriction of
the Cl  pathway by aN, aF, and aD helices, all of which point their N-terminal ends towards the cen-
ter where Cl -binding sites are formed. This arrangement contributes to an electrostatically positive
environment at the Cl -binding sites through a-helix end charges. Backbone nitrogen atoms from
aN and aF segments are arranged to coordinate a partially dehydrated Cl  ion near the extracellular
end of the constriction (external site or Sext). In the CLC-1 density map we observe a clear density
feature at Sext, which likely corresponds to a bound Cl
  ion (Figure 4A and Video 2). Typically, CLC
proteins have two additional Cl -binding sites, namely, central (Scen) and internal (Sint) sites
(Dutzler et al., 2003). Scen has been observed to bind a Cl
  ion through polar interactions with one
or two backbone nitrogen atoms and the side chains of the conserved tyrosine (denoted TyrC; Y578
of CLC-1 or Y445 of EcCLC) and serine residues (denoted SerC; S189 of CLC-1 or S107 of EcCLC)
(Dutzler et al., 2002; Dutzler et al., 2003). In the EcCLC transporter, Scen has been shown to bind
Cl  relatively strongly (Kd ~1 mM) (Lobet and Dutzler, 2006; Picollo et al., 2009). Sint is largely
exposed to the intracellular solvent and binds Cl  with lower affinity (Kd >20 mM) (Lobet and Dut-
zler, 2006; Picollo et al., 2009). In the CLC-1 map (determined in the presence of 116 mM Cl ), Sint
shows a density peak whose intensity is comparable to that of the Sext density (Figure 4A and
Video 2). By contrast, we do not observe density for an ion at Scen above the noise level, suggesting
that Scen of CLC-1 may have a lower Cl
  occupancy than Sext and Sint. This is somewhat surprising
given the conservation of structural elements for Scen, including TyrC and SerC. Perhaps subtle struc-
tural differences account for the absence of an ion at this site compared to other CLC proteins. For
example, we note that the position of TyrC is shifted away from Scen by ~1.5 A˚ (see Figure 5B).
New conformation of the gating glutamate
Like transporter-type CLC proteins and in contrast to CLC-K, the CLC-1 channel has a Glugate, but in
CLC-1 it adopts a notably different conformation than previously observed in CLC transporters (Fig-
ure 4 and Figure 4—figure supplement 1). Based on previous studies on transporters
(Dutzler et al., 2002; Dutzler et al., 2003; Feng et al., 2010), Glugate, located in the immediate
vicinity of Sext and Scen, plays a key role in ion transport: when deprotonated its side-chain carboxylic
moiety resides in either the Sext or Scen Cl
  binding sites, preventing the binding of a Cl  ion therein.
In the CLC-1 structure, the Glugate side chain occupies neither Sext nor Scen, but instead it is oriented
in a different direction. The difference in Glugate’s conformation is mainly due to changes in its side-
chain rotamer, whereas the polypeptide backbone arrangement in this region is similar among the
structures (Figure 4C). The observed Glugate conformation is also different than the outwardly-ori-
ented (side chain projecting into the extracellular funnel) conformation that has been seen in the
structure of an EcCLC Glu-to-Gln (E148Q) mutant (Figure 4C), which is hypothesized to mimic the
protonated state of Glugate (Dutzler et al., 2003).
It is unclear whether the Glugate in the CLC-1 structure (determined at pH 7.4) is protonated. The
pKa of the Glugate side chain might be shifted towards a more neutral pH as it is neighbored by mul-
tiple hydrophobic amino acids (Isom et al., 2010). Yet, Glugate at this position is more likely deproto-
nated because its side chain seems exposed to water molecules due to the presence of the second
intracellular pore (Figure 4B). In CLC transporters, this conformation would be highly unfavorable
because it would produce steric clashes with neighboring side chains (equivalent to V236, V265, and
F279 of CLC-1; Figure 4—figure supplement 1), which are moved away in CLC-1 by a shift of the
aG and aH helices. In other words, this conformation of Glugate does not seem possible in CLC
transporters studied so far.
The observed Glugate conformation of CLC-1 was unexpected because it was never observed in
other CLC protein structures, and yet it is consistent with an open CLC-1 channel, which is expected
in the absence of an applied membrane potential. CLC-1 is a voltage-gated channel, which closes
when the membrane potential is negative (i.e., at its ‘resting’ value) (Fahlke et al., 1996;
Park and MacKinnon. eLife 2018;7:e36629. DOI: https://doi.org/10.7554/eLife.36629 6 of 24
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Pusch et al., 1995). Perhaps in the presence of an applied negative membrane potential the Glugate
side chain moves into either the Sext or Scen position, as seen in CLC transporters, and prevents Cl
 
conduction. This possibility would account for the observation that CLC-1 and related CLC-0 con-
duct Cl  ions at all membrane voltages when the Glugate residue is mutated to Gln (Dutzler et al.,
2003; Fahlke et al., 1997).
**
*
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Figure 3. Bifurcated pore structure of the CLC-1 channel. (A) The canonical Cl  transport pathway (green) and the second intracellular pore (yellow) are
depicted in a side view of CLC-1. The pores of only one monomer are shown for simplicity. (B) Surface electrostatistics of CLC-1’s pore lining. The
protein surface was clipped to show optimally the pore lining of the CLC-1 monomer on the left. The yellow arrowhead indicates the position of the
selectivity filter. The insets show views into the pore entrances, which are marked with asterisks. (C) A view into the second intracellular pore entrance
from the cytosolic surface was compared to equivalent views with other CLC proteins. In the CLC-1 panel, the pore is indicated by a dashed gray circle.
Amino acids lining the pore were indicated with their side chain atoms shown in ball-and-stick representation.
DOI: https://doi.org/10.7554/eLife.36629.008
The following figure supplement is available for figure 3:
Figure supplement 1. Comparison of the second intracellular pore among CLC proteins.
DOI: https://doi.org/10.7554/eLife.36629.009
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Figure 4. Glutamate gate (Glugate) and Cl
 -binding sites of CLC-1. (A) View (stereo) into the selectivity filter of
CLC-1. aN, aF, aR, and aC-D segments (Ca trace and side chains) are shown in cyan, salmon, yellow, and olive,
respectively. The side chains of Glugate, TyrC, and SerC are represented with balls and sticks. Cl
 -binding sites are
indicated by green (Sext and Sint) and gray (Scen) spheres. The cryo-EM density map is shown in mesh (Sext and Sint
in magenta and the rest in gray). (B) Water-accessible regions in the filter region, probed by Hollow (Ho and
Gruswitz, 2008), are shown with purple (extracellular vestibule) and blue (intracellular vestibule) dots. Glugate is
Figure 4 continued on next page
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‘Transporter-like’ aC-D loop
The previous CLC-K channel structure has suggested that a wider pore diameter between Scen and
Sint is crucial for its channel function (Park et al., 2017). In CLC transporters, a kinetic barrier for Cl
 
passage (i.e., a narrowing of the pore) exists on the intracellular side of the vestibule to preclude
slippage of Cl  ions during the Cl /H+ exchange cycle (Feng et al., 2010). This barrier is due to a
narrow pore width between Scen and Sint, which is created in part by SerC of the aC-D loop inter-
posed between the two Cl  binding sites. In the CLC-K structure, the aC-D loop has a distinctly dif-
ferent conformation, where SerC is flipped down and thus no longer interposed between the two
Cl  binding sites. Consequently, the pore diameter is wider such that Cl  ions will more readily per-
meate. Given that CLC-1 is also a channel, we wondered whether the aC-D loop in CLC-1 would
adopt a similar ‘flipped-down’ conformation.
While a different conformation of the aC-D loop is a key feature distinguishing CLC-K from trans-
porters, a structural comparison shows that this is not the case for the CLC-1 channel (Figure 5). In
contrast to CLC-K, the aC-D loop in CLC-1 adopts the loop conformation seen in CLC transporters,
especially CmCLC (Feng et al., 2010). Consequently, the SerC side chain is positioned between Sint
and Scen (Figure 5B). Therefore, in the case of CLC-1 the aC-D loop itself does not provide an expla-
nation for why CLC-1 functions as a Cl  channel (see below). This also suggests that the ‘flipped-
down’ conformation of SerC may be unique to the CLC-K channel.
Comparison of Cl  pore structures of CLC proteins
To understand why CLC-1 functions as a channel we compared its Cl  pore structure to that of other
CLC proteins. In both CLC-1 and CLC-K channels, a continuous Cl  pathway was evident in between
the extracellular and intracellular funnels,
through the selectivity filter (Figure 6A,B). In the
EcCLC and CmCLC transporters, a continuous
pore could be detected only when the Glugate
side-chain atoms (from Cb) were excluded from
the pore radius calculation as Glugate sits at Sext
or Scen (Figure 6C,D). These results would there-
fore reflect the pore structure when the trans-
porter’s Glugate transiently moves away from the
Cl  pathway upon protonation (hypothetically,
akin to the crystal structure of the EcCLC E148Q
mutant). However, we note that calculated pore
radii around Sext may be somewhat overesti-
mated due to the actual presence of the Glugate
side-chain atoms.
The CLC-1 channel has the narrowest (1.0 A˚
in radius) constriction above Sext toward the
extracellular side due to the placement of the
M485 side chain near the external end of the Cl 
pathway (Figure 6A). While the radius is
Figure 4 continued
represented in ball-and-stick. (C) Comparison of Glugate positions between the CLC-1 channel and CLC
transporters. The amino acid segments 146–149 and 355–358 forming the anion selectivity filter were aligned
between structures. Ca-traces of the segments are shown with the Glugate side chains in ball-and-stick
representation. Blue, CLC-1. Light orange, WT EcCLC (PDB ID: 1OTS). Yellow, EcCLC E148Q mutant (PDB ID:
1OTU). Magenta, CmCLC (PDB ID: 3ORG). Gray spheres represent the positions of Cl  ions seen in EcCLC E148Q
mutant (Sext and Scen). Note that the Cl
  ion at CLC-1’s Sext (not shown) essentially coincides with Sext of EcCLC.
DOI: https://doi.org/10.7554/eLife.36629.010
The following figure supplement is available for figure 4:
Figure supplement 1. Comparison of the anion selectivity filter and Glugate between CLC proteins.
DOI: https://doi.org/10.7554/eLife.36629.011
Video 2. Glutamate gate (Glugate) and Cl
 -binding
sites of CLC-1. The selectivity filter region of human
CLC-1 is shown. The same color scheme and
representation are used in Figure 4A.
DOI: https://doi.org/10.7554/eLife.36629.013
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significantly smaller than the Cl  radius (~1.7 A˚), the flexibility of the M485 side chain must allow Cl 
ions to pass through this region. Given the narrowness of this constriction, it is likely that M485
affects the Cl  throughput of the channel. In fact, its mutation to less flexible valine (M485V) causes
recessive myotonia congenita and has been shown to reduce the single channel conductance of
CLC-1 to about 20% of the wild type channel conductance (Wollnik et al., 1997).
From Sext to the intracellular opening the CLC-1 channel structure shows a relatively wide pore
opening despite its ‘transporter-like’ aC-D loop. This suggests the absence of a large kinetic barrier
in CLC-1, but for reasons other than the aC-D loop conformation. Compared to the CLC-K channel,
CLC-1 has a slightly narrower (1.5 A˚ vs 1.7 A˚ in radius) opening between Scen and Sint because of
SerC. This might create a kinetic barrier to some degree, but the pore is still significantly wider and
more hydrophilic than the equivalent region in the EcCLC transporter (Figure 6C). The difference
originates mainly from two amino acids (T475 and G483) lining the constriction. In EcCLC, the equiv-
alent positions are F348 and I356, which project their bulky, hydrophobic side chains towards the
Cl  pathway between Scen and Sint. Together with proximal placement of SerC and TyrC, this narrows
the opening (1.0 A˚ in radius) in EcCLC. In the CmCLC transporter, the constriction at the kinetic bar-
rier region is wider (1.6 A˚ in radius) than EcCLC because of smaller side chains at the equivalent posi-
tions (I421 and V429; Figure 6D) and a slight downward shift (1.5 A˚) of SerC with respect to the
positions in EcCLC (Figure 5B). Yet, hydrophobicity provided by the I421 and V429 side chains
might result in a significantly higher kinetic barrier than in CLC-1.
It is noteworthy that the CLC-1 channel shows a 1.5 A˚ outward shift of the TyrC side chain with
respect to the position that is almost invariant in the other CLC structures (Figure 5B). In CLC-1, this
SerC TyrC
αC
αD
αR
hCLC-1 bCLC-K(Cl− channels)
(Cl− /H+ transporters) EcCLC CmCLC
TyrCSerC
Scen (EcCLC)
Sext (EcCLC)
45?
αC
αD
αC
αD
S189 S189
A
B
Figure 5. Structure of the aC-D loop and SerC. (A) Atomic model and cryo-EM density of the CLC-1 aC-D. (B) Comparison of the aC-D and aR
segments (shown in Ca-only trace) among CLC channels and transporters. The side chains of SerC and TyrC are shown in sticks.
DOI: https://doi.org/10.7554/eLife.36629.012
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shift contributes to pore widening in the cytosolic vestibule. At present it is unclear if this shift of
TyrC is static or part of dynamic movements in CLC-1 and if it is unique in CLC-1 or a similar move-
ment exists in other CLC proteins. Previous biophysical studies have proposed a movement of TyrC
to explain alternating gate opening of the EcCLC Cl /H+ transporter (Basilio et al., 2014;
Jayaram et al., 2008; Khantwal et al., 2016). On the other hand, EcCLC crystal structures obtained
with a number of different variants and crystallization conditions have not yet revealed any move-
ment of TyrC.
Distinctive amino acid pattern between CLC channels and transporters
around the kinetic barrier region
Because the CLC-1 structure suggests that T475 and G483 (equivalent to F348 and I356 in EcCLC,
respectively) likely contribute to lowering of the kinetic barrier, we compared amino acids lining this
bCLC-K channel
T417
0.9 2.01.45
Pore radius (Å)
Y425
F519
S121 (SerC)
Y520 (TyrC)
V166
Sint
Scen
CmCLC transporter
E210 (Glugate)
Y515 (TyrC)
I421
L514
S165 (SerC)Sint
Sext
V429
V431
M427
hCLC-1 channel
EcCLC transporter
Ext
Int
E232
(Glugate)
Y578 (TyrC)
L577
T475
M485
Sext
S189 (SerC)
Sint
E148
(Glugate)
Y578 (TyrC)
L444
F348
A358
S107 (SerC)
Sint
Scen
I356
G483
A B
DC
Figure 6. Profile of the Cl  transport pore and the kinetic barrier between Scen and Sint. Pore structures along the
Cl  pathway are shown in dot representation together with amino acids around it. Glugate, TyrC, and SerC side
chains are shown in ball-and-stick representation. The color scheme is the same as in Figure 4. Pore-lining amino
acids that are distinctive between CLC channels and transporters are shown in gray.
DOI: https://doi.org/10.7554/eLife.36629.014
The following figure supplement is available for figure 6:
Figure supplement 1. Sequence comparison of selected amino acids forming the ion selectivity filter and the
pore lining.
DOI: https://doi.org/10.7554/eLife.36629.015
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region among both CLC channels and transporters (Figure 6—figure supplement 1). Indeed, these
two positions showed a distinctive differential pattern when comparing CLC channels and transport-
ers, whereas other positions (i.e., H369, C481, L577, and I581 in CLC-1) did not. Generally, these
two positions are filled with large, hydrophobic amino acids in transporters but are replaced by a
small, polar amino acid in CLC channels. One notable outlier is position 417 of the CLC-K channels
(Y425). However, the CLC-K channel structure shows that its phenyl side chain is skewed off the Cl 
pathway, and thus does not seem to create a kinetic barrier in CLC-K (Figure 6B). In fact, it forms
the Scen Cl
  binding site together with TyrC and F519 through anion-quadrupole interactions
(Park et al., 2017) (Figure 6B). In summary, the observed amino acid pattern and structural informa-
tion suggest that a lowered barrier in the Scen–Sint region of the pore is a common feature of CLC
channels, but CLC-1 and CLC-K channels achieve this somewhat differently. In the CLC-1 channel,
small side chains in pore-lining residues lower the kinetic barrier, whereas in CLC-K mainly the reori-
entation of SerC lowers it. The extent of the kinetic barrier should also be affected by the hydropho-
bic and electrostatic nature of the lining residues, not only the physical dimensions of the pore.
Working model and experimental validation
Combining the new structural information and previous data, we propose a working model that
channel behavior in CLC proteins arises out of the following physical conditions (Figure 7): (1) Glu-
gate is either absent (i.e., in CLC-K) or allowed to reside in an ‘open’ configuration (i.e., CLC-1) for a
sufficiently extended period of time (rather than occupying Sext or Scen); (2) a lowered kinetic barrier
between Scen and Sint; (3) reduced Cl
 -binding affinity at Scen (or Sext, as suggested by apparent low
occupancy in the CLC-K structure). A reduced kinetic barrier would be an important feature to
achieve fast Cl  throughput. On the other hand, a sufficient kinetic barrier would be crucial in trans-
porters to preclude undesired slippage of Cl  ions through the transiently open pore (Feng et al.,
2010). In addition, reduction of Cl -binding affinity at Scen and/or Sext, which is energetically related
to the kinetic barrier, might also contribute to high Cl  throughput in channels. For example, rela-
tively deep energy wells at Scen and Sext, as implied by the high occupancy of sites in the EcCLC
transporter, would create a larger energy difference between the binding sites and the ‘transition
states’, which effectively raises the energy barrier. In CLC-1 the relatively low binding site occupancy
implies not very deep energy wells and thus a smaller energy difference between the binding sites
and ‘transition states’.
We carried out biophysical experiments to test some of these ideas using the EcCLC transporter
(Figure 8A,D). EcCLC mutants were produced, purified and reconstituted into lipid vesicles for
assessment of Cl  and H+ transport activity (Figure 8 and Figure 8—figure supplement 1)
(Feng et al., 2012; Jayaram et al., 2008; Walden et al., 2007). The ideas outlined above predict
that if the kinetic barrier in EcCLC is lowered it should behave more like a CLC channel (i.e., rapid
Cl  permeation with decreased H+ transport activity). Cl  permeation is expected to be further
increased if the Glugate is rendered persistently opened. As reported previously (Jayaram et al.,
2008), opening of Glugate alone by the Glu-to-Ala mutation (E148A) abolishes the H
+ transport activ-
ity, but it also reduced Cl  throughput by a factor of approximately 0.25. We reason that this is likely
because the mutant still retains the kinetic barrier deterring Cl  ions from moving between Scen and
Sint. Thus, while removal of the Glugate is sufficient to convert the transporter into a Cl
  channel, a
reduced kinetic barrier would be key to an increased Cl  throughput, an important feature of the
native CLC channels.
Previous studies have shown that when the E148A mutation is combined with a TyrC mutation (e.
g., Y445S), the Cl  transport rate dramatically increases (Jayaram et al., 2008), demonstrating that
efficient Cl  channel activity can be produced from EcCLC by altering its gates. However, we note
that Y445S is rather unphysiological as TyrC is invariant among all CLC channels and transporters.
Therefore, here we examined the effects of lowering the kinetic barrier in wild type EcCLC by mutat-
ing SerC or neighboring pore-lining amino acids, guided by the CLC-1 and CLC-K structures
(Figure 8B,E and Figure 8—figure supplement 1). Trimming the side chain of SerC (S107G), with
the intention of mimicking the flipped SerC in the CLC-K channel, increased the Cl
  transport rate
by a factor of 2, as previously reported (Jayaram et al., 2008). At the same time, this mutation low-
ered H+ coupling 3-fold, as one would expect due to the slippage of uncoupled Cl  ions. Next, since
CLC-K has a polar amino acid (Thr) at one of its pore-lining residues (F348 of EcCLC), we further
introduced a similar (F348A) mutation. This increased the Cl  throughput and almost abolished
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coupled H+ transport. Finally, by adding a Glugate mutation (E148A) to this double mutant the Cl
 
throughput was further increased. Compared to the E148A single mutant, the triple mutant (S107G/
F348A/E148A) has a Cl  transport rate increased about 25-fold (Figure 8—figure supplement 1).
Similar results were obtained when mutations mimicking the CLC-1 channel were introduced to
EcCLC (Figure 8C,F and Figure 8—figure supplement 1). While single mutations at the pore-lining
amino acids (F348T or I356G) did not increase the Cl  transport rate, the double mutation (F348T/
I356G) moderately increased the Cl  throughput (1.5-fold with respect to the wildtype). We note
that this mutant displayed no measurable H+ transport activity. When the double mutant was com-
bined with the Glugate mutation (E148A), which was used as a surrogate of the Glugate conformation
observed in the CLC-1 structure, the Cl  throughput dramatically increased (22-fold with respect to
the single E148A mutant; Figure 8—figure supplement 1). Single mutations (F348T or I356G) in the
CLC Transporters
CLC-1 Channel
CLC-K Channels
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Figure 7. Models for ion transport mechanisms of CLC transporters and channels. (A) General architecture of CLC proteins. F348 and I356 are labelled
according to E. coli transporter (EcCLC) numbering. (B) Model for 2:1 Cl /H+ exchange by CLC transporters. The negatively-charged carboxylic group
of the Glugate side chain can occupy Sext (state 2) or Scen (state 3) by a swinging motion, competing with a Cl
  ion for binding therein. When protonated
at Scen by a proton transferred from the cytosol (state 4), the Glugate side chain flips out to the extracellular side (state5). The kinetic barrier between
Scen and Sint would prevent leakage of Cl
  ions through the open pore during this transient step. Also, as seen previously with EcCLC (Picollo et al.,
2009), synergistic binding of two Cl  ions at Sext and Scen (depicted by solid gray curves around Sext and Scen) might further deter slippage of Cl
  ions.
Deprotonation resets the cycle (state1). The cycle is reversible, and for simplicity the intermediate steps were omitted. Cl  ions and H+ are depicted as
green and blue spheres, respectively. (C) Model for the CLC-1 channel. The cryo-EM structure of CLC-1 presented in this study represents the
depolarized state. Although the conformation of the aC-D loop remains similar to that of transporters, CLC-1’s kinetic barrier is lower than transporters
due to the lack of additional kinetic barrier elements. In addition, weak Cl -binding affinity at Scen might facilitate rapid permeation of Cl
  ions along
the pore. When the membrane potential is negative (resting), the Glugate side chain may occupy Sext or Scen as in transporters, blocking the pore. (D)
Model for CLC-K channels. The outer gate is removed by a natural mutation of Glugate to valine (V166). The kinetic barrier is largely reduced due to a
flip-down of SerC, as well as lack of other kinetic barrier elements. The cryo-EM structure suggested that Sext and Scen have weaker Cl
 -binding affinity
than transporters (empty and with a semi-transparent Cl  sphere).
DOI: https://doi.org/10.7554/eLife.36629.016
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E148A background showed intermediate increases in Cl  throughput, suggesting that the effects of
these mutations are somewhat additive.
N
o
rm
a
liz
e
d
 f
lu
o
re
s
c
e
n
c
e
N
o
rm
a
liz
e
d
 f
lu
o
re
s
c
e
n
c
e
no CLC
WT
S106G
S106G/F348A
S106G/F348A/E148A
E148A
WT
F348T/I356G
F348T
F348T/I356G
/E148A
E
x
te
rn
a
l 
[C
l−
] 
in
c
re
a
s
e
 (
m
M
)
Time (s)
E
x
te
rn
a
l 
[C
l−
] 
in
c
re
a
s
e
 (
m
M
)
Time (s)
Time (s) Time (s)
no CLC
no CLC
E148A
S106G/F348A
S106G
WT
Vln
CCCP
Vln CCCP
WT
F348T
I356G
F348T/I356G
F348T/E148A
CBa
FED
A
Figure 8. Effects of Glugate and kinetic barrier mutations on Cl
  and H+ transport activities of EcCLC. (A) Schematics of the Cl  dump assay to measure
the Cl  transport rate of EcCLC. Purified EcCLC protein is reconstituted into proteoliposomes containing 300 mM KCl inside. Buffer outside the
liposomes was reduced to 150 mM K2SO4, lowering the Cl
  concentration outside to ~1 mM. Transmembrane ion flux was initiated by addition of the
K+-ionophore valinomycin (Vln) and the protonophore carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP). Increase of the Cl  concentration
outside the liposomes was monitored using a Cl -selective electrode. (B) and (C) Examples of raw traces of Cl  dump assays. Vln/FCCP was added at
t = 0. the gray arrowheads indicate addition of the b-octyl glucoside detergent to the reaction to release all Cl  from liposomes. (D) Schematics of the
fluorescence-based H+ influx assay to measure the H+ transport activity of EcCLC. EcCLC proteoliposomes containing 450 mM KCl inside were diluted
to buffer containing 450 mM potassium gluconate, lowering Cl  concentration outside to ~30 mM. The flux was initiated by addition of valinomycin at
t = 100 s. As H+ are transported into the vesicles by EcCLC, intravesicular pH drops, which can be monitored by the quenching of 9-amino-6-chloro-2-
methoxyacridine (ACMA) fluorescence. At the end of experiments (t = 1200 s), the protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP)
was added to release all H+ from the vesicles. (E) and (F) Examples of normalized fluorescence traces of ACMA-based H+ influx assay. Shown are means
(line and symbols) and s.e.m. (band) of 4 experiments.
DOI: https://doi.org/10.7554/eLife.36629.017
The following figure supplement is available for figure 8:
Figure supplement 1. Summary of relative Cl  and H+ transport activities of EcCLC mutants.
DOI: https://doi.org/10.7554/eLife.36629.018
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Discussion
The human CLC-1 channel exhibits interesting structural differences in the Cl  transport pathway
and the gates, which can explain why this protein functions as a Cl  channel instead of a Cl /H+ anti-
porter. The outer gate of the channel remains open because the carboxylic side-chain Glugate is
located off to the side, away from the Cl  transport pathway (Figure 4). The inner kinetic barrier
seems to be substantially lowered compared to transporters owing to a wider pore diameter near
the cytosolic side (Figure 6). The pore widening is subtle, but distinctive enough to reveal a pattern
separating channels and transporters at the protein sequence level (independent of the presence or
absence of a Glugate) (Figure 6—figure supplement 1).
The position of the Glugate residue in CLC-1 is unique among CLC structures so far observed. The
new Glugate position, where its carboxylic side chain is directed off to the side of the Cl
  pathway, is
enabled by a pocket that is large and hydrophilic (owing to its bifurcated pore structure) enough to
accommodate Glugate’s side chain. This pocket may also exist in other Glugate-containing CLC chan-
nels (i.e., CLC-0 and CLC-2) but does not seem to exist in transporters because of a different
arrangement of neighboring amino acids. It seems likely that this Glugate position is key to under-
standing why CLC-1 exhibits a stable open (i.e., conducting) state. On the basis of mutagenesis stud-
ies (Dutzler et al., 2003; Fahlke et al., 1997), the Glugate in CLC-0 and CLC-1 has been identified as
a ‘voltage sensor’ because its removal abolishes voltage-dependent gating. From this observation,
we would suggest that the position of Glugate (i.e., whether it resides off to the side, not occluding
the pore, or within the pore) depends on the transmembrane voltage and generally dictates gating
each CLC-1 monomer’s pore (also referred to as a ‘protopore’).
An unresolved issue raised by the new Glugate side chain conformation is this: if this conformation
corresponds to the conducting state, how is it favored by low pH outside (Rychkov et al., 1996)?
One possibility is the Glugate might be protonated in this conformation. Alternatively, low pH might
stabilize a conformation of Glugate outside the pore, as in the EcCLC E148Q mutant. This conforma-
tion would also remove Glugate from the pore and permit conduction. Finally, the pH effect might be
produced allosterically by protonation of an unidentified amino acid on the extracellular side. For
example, both CLC-2 and CLC-K channels are inhibited by external pH <6.5, but it has been shown
that a His residue (H532 of CLC-2 and H497 of CLC-K), which is located ~20 A˚ away from the pore,
is responsible for this effect (Gradogna et al., 2010; Niemeyer et al., 2009). This issue remains
unresolved for now.
Functional experiments using EcCLC provide support for our model that a low kinetic barrier in
the cytosolic vestibule is necessary for high Cl  transport rates, which are general characteristics of
native CLC channels (Figure 8 and also see (Jayaram et al., 2008)). The results indicate that a small
increase in the pore diameter and a decrease in hydrophobicity of the pore lining can substantially
lower the kinetic barrier. The structures, however, suggest that the extent might be somewhat less
in the CLC-1 channel than in the CLC-K channel because of CLC-1’s SerC ‘transporter-like’ conforma-
tion. This is in fact consistent with the observation that CLC-1 has vestigial H+ transport activity
(Picollo and Pusch, 2005) and a relatively slow Cl  throughput compared to that of CLC-K channels
(1.2–1.8 pS versus 20–30 pS of CLC-K) (L’Hoste et al., 2013; Saviane et al., 1999; Scholl et al.,
2006; Weinreich and Jentsch, 2001). What then causes the SerC to adopt its flipped-down confor-
mation in the CLC-K channel? In CLC-K, position 425 contains a bulky amino acid (Y425), in contrast
to other CLC proteins. In the canonical conformation SerC would sterically clash with Y425 (e.g., the
center-to-center distance between the SerC-Og and Y425-Ce atoms would become 2.3 A˚). We spec-
ulate that this steric incompatibility imposed by the unique Y425 might lead to the flipped-down
conformation of SerC in the CLC-K channel.
The observed low Cl  occupancy at Scen in the CLC-1 structure has a striking resemblance to pre-
vious crystallographic observations on EcCLC, wherein Scen remained unoccupied when experiments
were performed with TyrC mutants lacking H
+ transport activity or with pseudohalides, which perme-
ate without coupled H+ transport (Accardi et al., 2006; Nguitragool and Miller, 2006). It has been
shown that in EcCLC, low Cl  occupancy correlates with low anion binding affinity (Picollo et al.,
2009). This comparison suggests a reduced Cl  binding affinity at Scen in CLC-1, although further
biophysical measurements will be necessary to confirm this. We speculate that this feature contrib-
utes to reduced H+ transport and increased Cl  conduction. Possible causes underlying the altered
Cl  affinity include the shifted position of TyrC and subtle changes in positions and orientations of
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neighboring backbone nitrogen atoms coordinating the Cl  ion. For example, we note that CLC-0/
1/2 channels have smaller, more flexible residues (Gly or Ala) at the G483 position, in contrast to
Leu, Ile, or Val in CLC transporters.
CLC-1 is now the second structure of a channel-forming CLC, the first being CLC-K (Park et al.,
2017). One of the major features giving rise to channel behavior is a more conductive pore. The
structural differences giving rise to the higher Cl  conductivity are fairly subtle: the pore is slightly
wider and the chemical properties a little different, accounting for what we propose to be a reduced
kinetic barrier. We think there is a very important lesson here. Throughput rates in the range of 106
ions per second do not require a wide pore. We conclude that even if the pore in places is on aver-
age narrower than the ion, as long as the lining atoms are favorable to a conducting ion with respect
to their electrostatic and chemical properties, and as long as they are sufficiently dynamic (i.e. they
can move out of the way), then the ion can diffuse through. We offer as an example of this idea, the
selectivity filter of K+ channels (Zhou et al., 2001). The atomic structures show us that in fact the
pore’s radius between the K+ binding sites is smaller than the radius of a K+ ion. And yet some K+
channels approach throughput rates of 108 per second. It is not surprising to now understand that
the radius of the pore in CLC channels and transporters is not very different.
The structures of CLC-1 and CLC-K channels support the idea that CLC channels are ‘broken
transporters’ (Jayaram et al., 2008; Lı´sal and Maduke, 2008; Miller, 2006), where their channel
function is built upon a transporter structure with modifications of the gates. The structures demon-
strate that relatively small changes in the active site and ion transport pathway of a transporter gives
rise to channel function.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
Gene (Homo sapiens) CLCN1 Synthetic UniProt: P35523
Cell line (Homo sapiens) HEK293S GnTI- ATCC ATCC: CRL-3022
RRID:CVCL_A785
Cell line (Spodoptera
frugiperda)
Sf9 ATCC ATCC: CRL-1711
RRID:CVCL_0549
Recombinant DNA reagent pEG BacMam doi: 10.1038/nprot.2014.173
Software, algorithm RELION-2 doi: 10.1016/j.jsb.2012.09.006 https://www2.mrc-lmb.cam.ac.uk/
relion/index.php?title=Main_Page
Software, algorithm MotionCor2 doi:10.1038/nmeth.4193 http://msg.ucsf.edu/em/software/motioncor2.html
Software, algorithm CTFFIND4 10.1016/j.jsb.2015.08.008 http://grigoriefflab.janelia.org/ctffind4
Software, algorithm Alightpart_lmbfgs doi: 10.1016/j.jsb.2015.08.007 https://sites.google.com/site/
rubinsteingroup/direct-detector-align_lmbfgs
Software, algorithm Rosetta RosettaCommons RRID:SCR_015701 https://www.rosettacommons.org/software
Software, algorithm Pymol PyMOL Molecular Graphics
System, Schro¨dinger, LLC
RRID:SCR_000305 http://www.pymol.org/
Software, algorithm UCSF Chimera UCSF Resource for
Biocomputing, Visualization,
and Bioinformatics
RRID:SCR_004097 http://plato.cgl.ucsf.edu/chimera/
Protein expression and purification
Human CLC-1 was expressed in HEK293 GnTI  cells (ATCC CRL-3022) by transduction using a modi-
fied baculovirus as described previously (Goehring et al., 2014; Park et al., 2017). A human CLC-1
coding sequence (CDS) was synthesized and inserted into a modified pFastBac vector, which con-
tains a CMV promoter upstream of CDS. The expressed CLC-1 construct has a truncation of N-termi-
nal 80 amino acids (residues 2–80), which were predicted to be unstructured, and its C-terminus is
fused to enhanced green fluorescent protein (eGFP) (it also contains a HRV 3C protease cleavage
sequence between CLC-1 and eGFP). The vector was used for transformation of DH10Bac E. coli
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cells (Invitrogen) to generate a baculovirus bacmid. Baculoviruses were produced by transfecting
Spodoptera frugiperda (Sf9; ATCC CRL-1711) cells with the bacmid using Cellfectin-II (Invitrogen).
Viruses were then amplified twice for large-scale transduction. HEK293 GnTI  cells were grown at
37˚C in suspension in Freestyle 293 medium (Invitrogen) supplemented 2% FBS in the presence of
8% CO2. At a cell density of ~2.5  10
6 mL 1, baculovirus was added to the culture (6–8% v/v). After
incubating at 37˚C for ~0.5 day, the culture was supplemented with 10 mM sodium butyrate, then
further incubated at 30˚C for 2 days before harvest.
All protein purification steps were carried out at 4˚C. Harvested HEK293 cells (typically from 1 to
2 L) were suspended in a buffer containing 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 1 mM dithiothrei-
tol (DTT), 1 mM ethylenediaminetetraacetic acid (EDTA), and 10% v/v glycerol, and supplemented
with protease inhibitors (50 mM leupeptin, 1 ug/mL aprotinin, 1 uM pepstatin and 1 mM phenylme-
thylsulfonyl fluoride). 1% dodecyl-b-maltoside (DDM) and 0.2% cholesteryl semisuccinate (CHS) were
added to the cell suspension. After extraction for 1.5 h, the lysate was clarified by centrifugation
(Beckman Type 70Ti rotor, 40,000 RPM, 1.5 h). The clarified lysate was then mixed with 5 mL of
CNBr-sepharose beads (GE Healthcare) coupled with anti-GFP nanobody for 2.5 h. Beads were
washed on 60 mL of the buffer containing 0.04% DDM and 0.004% CHS. Bound protein was
released from beads by overnight incubation with 5 mL buffer containing 0.04% DDM, 0.004% CHS,
and 0.2 mg HRV 3C protease. The retrieved protein was concentrated to 0.5–1.0 mL using Amicon
Ultra (100 kDa cutoff; EMD Millipore) and applied to a Superose 6 300/10 GL column (GE Health-
care) equilibrated with 20 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM DTT, 0.5 mM EDTA, 0.04%
DDM, and 0.004% CHS. The peak fractions were pooled and concentrated to ~4 mg/mL, and imme-
diately used for cryo-EM grid preparation.
The wild-type and mutant E. coli CLC transporter proteins (EcCLC) were expressed and purified
essentially as described previously (Dutzler et al., 2002). E. coli BL21 (DE3) (Novagen) was trans-
formed by pET28b vector containing EcCLC CDS, the C-terminal of which was fused to a hexa-histi-
dine tag (His-tag). E. coli cells were grown at 37˚C in Luria broth (LB) medium containing 60 mg/mL
kanamycin until they reached OD600 of 1.2. The expression was induced by addition of 0.2 mM iso-
propyl b-D-1-thiogalactopyranoside (IPTG). The cells were further grown at 21˚C for ~16 h before
harvest by centrifugation. The cell pellets were frozen with liquid N2 and stored at  80˚C until purifi-
cation. The frozen E. coli cells (typically from 3 L) were thawed and suspended in 20 mM Tris-HCl pH
7.5 and 150 mM NaCl. The cells were lysed by sonication (1 mM PMSF and 50 uM leupeptin were
supplemented before the lysis), and 2% decylmaltoside (DM) and 10 mM imidazole were added.
After 2-h gentle stirring at 4˚C, the lysate was spun for 1 h at 15,000 rpm (Beckman JA-17 rotor).
The supernatant was mixed with 5 mL of Talon cobalt agarose beads (Takara Bio) for 2 h. The beads
were packed in a column and washed with 25 mL of lysis buffer containing 20 mM imidazole, 12.5
mL of buffer containing 30 mM imidazole, and then 12.5 mL of buffer containing 40 mM imidazole.
The protein was eluted by buffer containing 200 mM imidazole. The eluate was concentrated to ~0.5
mL using Amicon Ultra (50 kDa cutoff). The His-tag was removed by adding 0.5 U of Lys-C endopep-
tidase (Roche) and incubating the mixture at 23˚C for 3 h. The eluate was applied to a Superdex 200
300/10 GL column (GE Healthcare) equilibrated with 25 mM Tris-HCl pH 7.5, 100 mM NaCl, 1 mM
DTT, 0.5 mM EDTA, 10% glycerol, and 0.3% DM. The peak fraction was collected and used for
reconstitution without freezing.
Cryo-EM analysis
3 mL of purified CLC-1 protein was applied to a glow-discharged gold (or copper for the third data-
set) Quantifoil R 1.2/1.3 holey carbon grids (Quantifoil) and incubated for 15 s. Grids were then blot-
ted for 1.5–2.0 s at 4˚C and 90% humidity and plunge-frozen in liquid-nitrogen-cooled liquid using
Vitrobot Mark III (FEI).
The data sets were collected on a Titan Krios electron microscope (FEI) operated at an accelera-
tion voltage of 300 kV. Dose-fractionated images were recorded on a K2 Summit direct electron
detector (Gatan) operated in super-resolution counting mode (a super-resolution pixel size of 0.515
A˚) using SerialEM software (Mastronarde, 2005). For the first two datasets (2293 movies), the dose
rate was 8 e  per pixel per s, and total exposure time was 10 s with 0.2 s for each frame (total cumu-
lative dose of ~75 e  per A˚2 over 50 frames). For the third dataset (1998 movies), the dose rate was
5.33 e  per pixel per s, and total exposure time was 15 s with 0.15 s for each frame (total cumulative
dose of ~75 e  per A˚2 over 100 frames). Defocus values were set from  0.8 mm to  2.4 mm.
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Dose-fractionated movies were corrected for gain and motion by MotionCor2 (Zheng et al.,
2017). Also the pixels were binned to 1.03 A˚/pixel during this process. Defocus values were esti-
mated using CTFFIND4 (Rohou and Grigorieff, 2015) on the summed micrographs produced by
MotionCor2 (using the full dose). Particles were picked automatically by RELION2 (Kimanius et al.,
2016; Scheres, 2012), and obvious artifacts, such as ice contamination and carbon foil, were
removed by manual inspection. Total 725,959 particles were extracted with a box size of 320 pixels
and subjected to reference-free 2D classification (performed separately per dataset). Based on visual
inspection of quality of 2D average classes, 411,260 particles were pooled. This particle set was then
applied to the alignpart_lmbfgs program (Rubinstein and Brubaker, 2015) to perform per-particle
motion correction (particle polishing). The particle polishing step was done using motion-corrected
(whole-frame-only) movie stacks, which were first produced by MotionCor2 and then 2x or 4x frame-
binned by relion_image_handler (resulting in a total of 25 frames per movie and 3 e  per A˚2 per
frame). Particles were extracted from 1 to 13 frames (total dose of 39 e  per A˚2) and using align-
parts_lmbfgs’s exposure filter. The ‘polished’ particles were subjected to another round of clean-up
by RELION 2D classification (resulting in 350,750 particles). The initial model was generated by
RELION auto-refine using particle images from the first dataset and a 50 A˚ lowpass-filtered model
from the CLC-K channel density map (excluding antibody fragments; (Park et al., 2017)). All
350,750 polished particle images were subjected to auto-refine (RELION 2.1), using the updated ini-
tial model and a soft mask surrounding the protein and detergent micelle density. This refinement
step produced a 3.8 A˚ map (Figure 2—figure supplement 1B). This was then followed by a RELION
3D classification procedure skipping image alignment (sorting into five classes). Particles from two
classes were combined (175,613 particles) by visual inspection in UCSF Chimera (Pettersen et al.,
2004) and subjected to RELION auto-refine again. During the later iterations (upon entering the
local search mode), the soft mask was updated to contain only the transmembrane or cytosolic
domain (focused refinement). The resolution of the final TMD domain map (3.36 A˚) was estimated
by RELION based on gold-standard Fourier shell correlation (FSC) of independently refined half
maps (using the 0.143 cut-off criterion). The focused refinement of the cytosolic domain was per-
formed by 2 iterations of local refinement using reference maps in which information at lower than
4.6 A˚ resolution were combined from the previous iteration’s two half maps. The nominal resolution
of the final CTD map is 4.1 A˚, but this is likely somewhat overestimated (the resolution before the
focused refinement is 4.5 A˚). Local resolution was estimated using RELION2’s postprocess program
(Figure 2—figure supplement 1A). Unless stated otherwise, the TMD map shown in figures is a
combined map, which was sharpened (B-factor of  97.9 A˚2) and lowpass-filtered at 3.36 A˚ by
RELION’s automatic postprocess procedure using user-provided soft masks. The TMD map in
Figure 2C and Videos 1 and 2 was sharpened with a B-factor of  97.9 A˚2 and low-pass filtered at
3.1 A˚. The CTD density map was low-pass filtered at 4.2 A˚ without B-factor sharpening.
Atomic model building
An initial model of the CLC-1’s TMD was generated by the SWISS-MODEL homology modelling
webserver using the CLC-K model (PDB ID: 5TQQ) as a template. The output model was fit into the
TMD density map using Chimera and rebuilt using Coot (Emsley et al., 2010). Model refinement
was done in real space using Rosetta 3.7 using a script developed for cryo-EM model refinements
(Wang et al., 2016) (Table 1). The first round was performed with an asymmetric unit model, and
the five best output models were selected based on Rosetta’s energy scores. A consensus model
was generated by combining fragments from these models based on the fit to the density map. The
subsequent two rounds of Rosetta refinement were done with two-fold symmetry imposed. To pre-
vent overfitting, the weight between Rosetta energy scores and the fit to the experimental density
map was adjusted, and test refinement was performed on one of two half maps. The output models
were then compared to both half maps by calculating FSC (Figure 2—figure supplement 2). To this
end, we used a weight of 25, which gave us a good fitting to the map and negligible overfitting.
While the first two rounds of refinement were done using one of the two half maps, the last round
was performed on the combined map to maximize the use of experimental data in refining the
model (see Figure 2—figure supplement 2 for FSC between the final model and the combined
map). The final model was selected among ~2000 Rosetta-generated models based on Rosetta’s
total score (top 20%) and the fit of side chains to the map (visual inspection). No further modifica-
tions were made except for Cl  ions at Sext and Sint, which were modelled in Coot (Coot’s real-space
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refinement was used) since Rosetta could not refine Cl  ions. Modelling of CTD was done similarly
using Rosetta, but using a crystal structure of CLC-0 CBS domain as an initial model. A weight of 7
was used, and the refinement was limited to 4.5 A˚ resolution. As side chains were not visible in the
CTD density map, we removed all side chain atoms from the final CTD model generated by Rosetta.
The following segments were not modelled as they were invisible in the density maps: N–115, 251–
262 (a cytosolic segment between aF and aG), 671–796 (a loop in CTD), and 877–988(C). MolProbity
was used for structural validation of models (Table 1) (Chen et al., 2010).
Detection of pores and estimation of pore radii (Figures 3 and 6) were performed using Caver
(Chovancova et al., 2012). In the case of EcCLC (PDB ID: 1OTS) and CmCLC (PDB ID: 3ORG), Glu-
gate (E148 of EcCLC and E210 of CmCLC) was mutated to Ala before estimation since its side chain
is blocking the Cl  pathway. In the case of bovine CLC-K (PDB ID: 5TTQ) (Figure 6B), we changed
the rotamer conformation of V166 (equivalent to Glugate) from original gauche+ (63˚) to trans (175˚).
With the original rotamer, the constriction around Sext was found to be too narrow (radius < 0.9 A˚)
for pore detection. Because both rotamers can be fitted equally well into the cryo-EM density map,
it is uncertain which is right or if both can exist in the protein. We note that trans is in general an
energetically more favored rotamer than gauche+. Water accessibility in CLC-1’s vestibules
(Figure 4B) was probed using HOLLOW (Ho and Gruswitz, 2008) using a probe radius of 1.4 A˚.
Protein electrostatics were calculated using the Adaptive Poisson-Boltzmann Solver (Baker et al.,
2001) with a parameter of 150 mM monovalent salt concentration. UCSF Chimera and PyMOL
(Schro¨dinger) were used to prepare structure figures.
Table 1. Model refinement and validation statistics.
TMD CTD
Rosetta Model Refinement
Map pixel size (A˚) 1.03 1.03
Map sharpening B-factor (A˚2)  97.9 0
Map lowpass filter (A˚) 3.36 4.2
Refinement resolution limit (A˚) 3.36 4.5
Number of atoms 14,536 5124†
Protein 14,536 5124†
Non-hydrogen atoms 7152 2550†
Hydrogen atoms 7384 2574†
Non-protein 0 0
Refined Model Statistics
Average B-factor (A˚2) 24.59 161.34
r.m.s deviations
Bond length (A˚) 0.02 0.02†
Bond angle (˚) 1.42 1.55†
Ramachandran Plot
Favored (%) 96.75 96.15†
Outliers (%) 0.43 0.64†
MolProbity
Clash score*/percentile 1.38 (99 %) 0.39# (99%)
Rotamers
Favored (%) 99.48% 100.00# %
Outliers (%) 0.00% 0.0† %
Overall score/percentile 1.07 (100 %) 0.90† (100%)
*number of steric overlaps >0.4 A˚ per 1000 atoms.
†numbers and scores before truncation of side chain atoms.
DOI: https://doi.org/10.7554/eLife.36629.019
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Reconstitution of E. coli CLC transporter mutants and flux assays
To reconstitute EcCLC mutant proteins for Cl  efflux assays, E. coli polar lipids in chloroform (Avanti
Polar Lipids) was dried in a glass tube with an argon stream, followed by overnight incubation in a
vacuum chamber. Dried lipids were suspended by sonication in buffer (RB-Cit) containing 25 mM
sodium citrate (pH 4.6) and 300 mM KCl and then solubilized with 35 mM (3-((3-cholamidopropyl)
dimethylammonio) 1-propanesulfonate) (CHAPS; Anatrace) and additional sonication. Purified
EcCLC protein was added to the lipid/CHAPS mixture in a protein-to-lipid ratio of 1:5000 (wt:wt).
After 30 min incubation at 23˚C, the mixture was dialyzed against RB-Cit buffer to remove CHAPS.
The dialysis was carried out at 4–10˚C for 48 h with three additional buffer changes. To reconstitute
EcCLC proteins for fluorescence-based flux assays, the same procedure was used except that buffer
containing 10 mM HEPES-NaOH (pH 7.0) and 450 mM KCl instead of RB-Cit and a protein-to-lipid
ratio of 1:500 (wt:wt) were used. After dialysis, proteoliposome vesicles were aliquoted, flash-frozen
with liquid N2, and stored at  80˚C until use.
The Cl  efflux (dump) assays were performed essentially as described previously (Jayaram et al.,
2008; Walden et al., 2007). A frozen aliquot of vesicles was thawed and briefly sonicated in the
bath sonicator (Branson). Vesicles were extruded through a 0.4 mm polycarbonate filter 19 times
(Avanti Mini-Extruder). The extruded vesicles were desalted with a spin column packed with Sepha-
dex G-50 resin (~2.5 mL bed volume) equilibrated with buffer (EB) containing 25 mM sodium citrate
(pH 4.7), 250 mM K2SO4, and 1 mM NaCl. 100 mL of the desalted vesicles were then mixed with 900
mL EB in a chamber equipped with a magnetic stirrer and Cl -selective electrode (Fisher Accumet).
Changes in extravesicular Cl  concentration was monitored over time by the Cl -selective electrode
connected to a computer through a digitizer (DataQ). To calibrate the electrode, 0.1 mM NaCl was
added before the vesicles were added. Flux was initiated by addition of 2 mg/mL valinomycin and 1
mg/mL carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) or 3 mg/mL valinomycin (for
E148A mutants). At the end of assays, 30 mM octyl b-glucoside (Anatrace) was added to release all
Cl  content from vesicles. Calculation of Cl  transport rates were carried out as described previously
(Walden et al., 2007). Volume changes by dialysis, extrusion, and desalting steps were included in
calculation.
The fluorescence-based flux assays were performed as follows based on (Feng et al., 2012). A
frozen aliquot of vesicles was thawed and briefly sonicated in a bath sonicator. 3 mL of vesicles were
mixed with 40 mL of assay buffer containing 20 mM HEPES-NaOH (pH 7.0), 450 mM K-gluconate and
4 mM ACMA in a well of a 384-well fluorescence assay. After measuring initial AMCA fluorescence
intensity (lEx=410 nm, lEm=490 nm), Cl
 /H+ flux was initiated by addition of 1 mM valinomycin, fol-
lowed by monitoring fluorescence over time (10 s intervals) using a plate reader (Tecan Infinite
M1000) at 27˚C. Note that there is a dead time for measurement between t = 80 s to t = 120 s due
to handling of the plate during valinomycin addition. Valinomycin was added to the reactions at
t = ~100 s. As a control, 0.9 mM carbonyl cyanide 3-chlorophenylhydrazone (CCCP) was added to
the assay mixture at the end of the experiment to dissipate an accumulated H+ gradient. To measure
relative H+ transport activity of each mutant, time required to fluorescence reaches 75% (or 85% in
the case of S106G/F348A double mutant) of the initial fluorescence upon addition of valinomycin
was calculated. This time value was then inversed and normalized with respect to a value obtained
with wild-type EcCLC.
Data availability
Cryo-EM density maps of human CLC-1 have been deposited in the electron microscopy data bank
under accession code EMD-7544 and 7545. Atomic coordinates have been deposited in the protein
data bank under accession code 6COY and 6COZ.
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